The Chemours Newsroom

BMO Capital Maintains The Chemours(CC.US) With Buy Rating, Raises Target Price to $34

Futu NewsJan 8 20:34

Goldman Sachs Maintains The Chemours(CC.US) With Hold Rating, Cuts Target Price to $21

Futu NewsJan 8 01:32

Chemours Is Maintained at Neutral by Goldman Sachs

Dow JonesJan 7 22:29

Chemours Price Target Cut to $21.00/Share From $24.00 by Goldman Sachs

Dow JonesJan 7 22:29

Chemours Analyst Ratings

BenzingaJan 7 22:20

Mizuho Securities Maintains The Chemours(CC.US) With Hold Rating, Announces Target Price $21

Futu NewsJan 7 02:31

Mizuho Trims Price Target on Chemours to $21 From $22, Maintains Neutral Rating

MT NewswiresJan 6 22:37

Morgan Stanley Maintains The Chemours(CC.US) With Hold Rating, Maintains Target Price $25

Futu NewsDec 21, 2024 02:40

Jefferies Maintains The Chemours(CC.US) With Hold Rating, Raises Target Price to $21

Futu NewsDec 16, 2024 21:33

Chemours Analyst Ratings

BenzingaDec 13, 2024 00:21

RBC Capital Maintains The Chemours(CC.US) With Buy Rating, Maintains Target Price $25

Futu NewsDec 12, 2024 20:32

RBC Capital Maintains The Chemours(CC.US) With Buy Rating, Cuts Target Price to $25

Futu NewsNov 6, 2024 20:36

Chemours Is Maintained at Equal-Weight by Morgan Stanley

Dow JonesNov 5, 2024 21:32

Chemours Analyst Ratings

BenzingaNov 5, 2024 21:22

Barclays Maintains The Chemours(CC.US) With Hold Rating, Raises Target Price to $23

Futu NewsNov 5, 2024 17:39

Mizuho Securities Maintains The Chemours(CC.US) With Hold Rating

Futu NewsNov 5, 2024 14:32

Morgan Stanley Maintains The Chemours(CC.US) With Hold Rating, Maintains Target Price $30

Futu NewsNov 5, 2024 10:34

Mizuho Securities Maintains The Chemours(CC.US) With Hold Rating, Cuts Target Price to $22

Futu NewsOct 15, 2024 02:31

RBC Capital Maintains The Chemours(CC.US) With Buy Rating, Cuts Target Price to $28

Futu NewsOct 11, 2024 21:31

UBS Maintains The Chemours(CC.US) With Buy Rating, Cuts Target Price to $26

Futu NewsOct 9, 2024 00:31